Abstract
Bone regeneration requires a well-orchestrated cellular and molecular response including robust vascularization and recruitment of mesenchymal and osteogenic cells. In femoral fractures, angiogenesis and osteogenesis are closely coupled during the complex healing process. Here, we show with advanced longitudinal intravital multiphoton microscopy that early vascular sprouting is not directly coupled to osteoprogenitor invasion during calvarial bone regeneration. Early osteoprogenitors emerging from the periosteum give rise to bone-forming osteoblasts at the injured calvarial bone edge. Microvessels growing inside the lesions are not associated with osteoprogenitors. Subsequently, osteogenic cells collectively invade the vascularized and perfused lesion as a multicellular layer, thereby advancing regenerative ossification. Vascular sprouting and remodeling result in dynamic blood flow alterations to accommodate the growing bone. Single cell profiling of injured calvarial bones demonstrates mesenchymal stromal cell heterogeneity comparable to femoral fractures with increase in cell types promoting bone regeneration. Expression of angiogenesis and hypoxia-related genes are slightly elevated reflecting ossification of a vascularized lesion site. Endothelial Notch and VEGF signaling alter vascular growth in calvarial bone repair without affecting the ossification progress. Our findings may have clinical implications for bone regeneration and bioengineering approaches.
Similar content being viewed by others
Introduction
Despite substantial advancements in our understanding of the mechanisms underlying bone regeneration, major challenges in orthopedic surgery remain due to failing or delayed fracture healing and complications during bone repair1,2. Segmental bone defects caused by trauma, infections and tumors associated with insufficient osteogenesis often result in significant disabilities in patients3,4,5. The reasons for failed bone regeneration and non-union fractures often remain unclear6,7. Bone repair is achieved through a highly complex and interconnected series of cellular and molecular events orchestrated by various mediators and signaling factors. In long bone, fracture healing involves several distinct stages starting with early hematoma formation, followed by a reparative and remodeling response8,9,10. Critical steps in the progression of bone repair are robust vascularization and recruitment of mesenchymal and osteogenic cells to the site of injury8,11,12. Vascularization and osteogenesis are closely coupled during this process through specialized blood vessels that provide paracrine signals to coordinate osteoprogenitor migration and differentiation in bone development and regeneration13,14. The signaling interactions that regulate co-invasion of osteoprogenitors with blood vessels during fracture repair are still poorly understood15. Candidate mediators involved in osteo-angiogenic coupling are components of the vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF) pathways, Notch and, more recently, platelet derived growth factor receptor beta (PDGFRβ) signaling13,16,17. PDGFRβ has been suggested to be a critical functional driver for mesenchymal skeletal stem cell activation, migration and angiotropism during bone repair18. In the initial phase, the hematoma creates a special milieu of signaling factors, including chemotactic factors and cytokines, to attract inflammatory cells10,19. While macrophages clear the necrotic tissue and fibrin degradation products10,20, inflammatory cells release chemotactic and growth factors to promote the recruitment of various cell types including vascular endothelial cells, mesenchymal stromal cells (MSCs) and fibroblasts. At the fracture site, MSCs proliferate and differentiate in close proximity to blood vessels into osteoprogenitors and osteoblasts to promote bone regeneration19,21,22. Long bone fractures typically involve interfragmentary strain that induces chondroid soft callus formation consisting of strain-absorbing extracellular matrix23. Hypertrophic chondrocytes secrete cytokines and growth factors to attract vascular endothelial cells and osteoprogenitors. Sprouting capillaries originate from the periosteal and intramedullary vasculature24,25 and infiltrate the avascular callus in close association with osteoprogenitors to promote callus remodeling and endochondral ossification10,23,26. HIF signaling, strain and vascularization are absolutely essential for bone repair10,12 and dictate the type of ossification that occurs, either by direct intramembranous ossification and/or by endochondral ossification involving a cartilage intermediate10,27. Small, stabilized fractures, i.e. drill hole lesion injuries in femur28,29 or calvarium30 heal in absence of interfragmentary strain by intramembranous ossification. Calvarial lesion injuries have been used previously to study vascularization and ossification31,32, the oxygen microenvironment31 and bioactive tissue transplants33,34 in bone regeneration. However, the highly dynamic and complex cellular interactions including cell proliferation, migration and differentiation and their timely coordination and regulation during calvarial bone healing still remain poorly understood.
In recent decades, major developments in imaging technologies, in particular confocal and multiphoton microscopy as well as microcomputed tomography, have significantly improved our understanding of the microarchitecture and specialized functions of various tissues, including the bone and bone marrow (BM) environment14,35,36. In mice, intravital multiphoton imaging of the calvarium and long bones have been used to visualize trafficking and dynamic behavior of cells in the BM37,38,39,40, blood flow dynamics in BM microvessels41, vascular plasticity42 and bone regeneration31,43.
The study of regenerative processes in the bone using intravital multiphoton microscopy is challenging, since bone is an optically dense and highly scattering tissue. Here, we present a greatly improved methodology of longitudinal intravital imaging, which allows to visualize repeatedly in a single living animal the highly complex process of calvarial bone healing after lesion injury at a multiscale level until lesion closure using high-resolution multiphoton microscopy. This advanced imaging approach enables us to visualize and track how i) regenerating blood vessels vascularize the calvarial bone lesion and establish a mature and perfused vascular network, ii) vascular sprouts and early osteoprogenitors migrate into the bone lesion in a spatiotemporal fashion, iii) bone-forming osteoblasts initiate and progress the formation of new bone until lesion closure, and iv) activation and inhibition of endothelial Notch, and enhanced VEGF-A signaling affect blood vessel sprouting and remodeling without impacting ossification of the healing bone. Furthermore, we compare calvarial lesions with femoral fractures with regard to vascularization and association with osteoblastic cells and identify striking differences in osteo-angiogenic coupling during bone repair. Single-cell RNA sequencing (scRNA-seq) results provide insight into bone stromal cell heterogeneity and expression of genes related to angiogenesis and oxygen sensing during bone regeneration. The full scRNA-seq data is accessible through an online cell viewer platform allowing easy and rapid interrogation of results.
Results
Vascular regeneration and calvarial bone healing after lesion injury
To gain insight into the dynamic vascular changes after calvarial bone injury, we generated drill hole lesions in the parietal skull bone of Flk1-GFP+ reporter mice. The labeling of ECs allows the monitoring of vascular growth and remodeling processes in the lesion using longitudinal intravital multiphoton microscopy (Fig. 1a–c). An optical cranial window was mounted on the injured bone and imaged in intervals of typically three days over a period of up to six weeks. After an initial avascular phase, first Flk1-GFP+ endothelial sprouts emerge from the underlying vascular network around post-lesion day (PLD) 6 and show a characteristic tip cell morphology with filopodial extensions (Fig. 1c). Whole mount analysis of the calvarium at PLD3 and 6 reveals that early Flk1-GFP+ sprouts originate from the meningeal vascular network (Supplementary Fig. 1a–e). Second-harmonic generation (SHG) imaging allows simultaneous visualization of Flk1-GFP+ vessels and calcified collagen network in the bone tissue. Bone lesions appear as circular dark areas, surrounded by the adjacent SHG+ calvarial bone (Fig. 1c). In the following days, profound and robust sprouting angiogenesis results in vascularization of 34 ± 3% of the defect area by PLD9 (Fig. 1c, e). Then, outward growing vascular sprouts emerge from the early vascular network and connect with outer periosteal vessels around PLD9-12 (Fig. 1c, Supplementary Fig. 1e, f). At the same time, Flk1-GFP+ microvessels closely align with the surface of the adjacent injured calvarial bone (Supplementary Fig. 1f). These bone-aligned microvessels become part of a dense vascular network that covers the complete lesion area. Repetitive imaging of selected areas allows tracking of the dynamic vessel sprouting and remodeling processes in the lesion and reconstruction of the resulting vascular changes (Supplementary Fig. 2a). Endothelial sprouting generates new connections between existing microvessels and thereby establishes new vascular branch points. In the same period, nearby EC tubes are subjected to pruning, leading to the loss of vascular connections (Supplementary Fig. 2b). Robust and highly dynamic vascular sprouting is followed by a phase of extensive vascular remodeling during which the newly formed vasculature is embedded in the healing bone (Fig. 1d). This process continues in the following weeks and significantly reduces vascular density to reach a vascular area of 20 ± 1% in the lesion around 3-weeks post-lesion (Fig. 1e, f).
Deposition of new SHG+ bone matrix is first observed around PLD9 at the injured edge of the calvarial bone (Supplementary Fig. 2c). The ossification process advances with new bone steadily growing inwards from the adjacent ossified areas, resulting in lesion closure over a period of 4-5 weeks (Fig. 1d, e). The velocity of local bone formation varies considerably in the range of 249 ± 154 µm2/h, however, averaged across the whole lesion, growth is steady during the observation period (Fig. 1e, Supplementary Fig. 2c). Collagen fibers of the new bone matrix assemble a dense and interconnected three-dimensional network with an average fiber diameter of 2.2 ± 0.2 µm at the growing front (Fig. 1d, Supplementary Fig. 2d). Flk1-GFP+ microvessels are located in close proximity to these collagen fibers and are frequently surrounded by growing bone, which leads to the formation of early bone marrow-like cavities (Fig. 1d, f). The SHG+ fiber network in the uncalcified lesion is clearly distinct from the growing bone. These collagen fibers are thinner and show a parallel alignment (Supplementary Fig. 2c, d). Flk1-GFP+ vascular sprouts are typically in close proximity or attached to SHG+ fibers, indicating that endothelial cells might extend along these collagen fiber scaffold, as reported previously44 (Supplementary Fig. 2d). Taken together, these results provide a spatiotemporal framework for vascular growth during bone generation in the calvarium.
Vascular connectivity and blood flow in regenerating bone
Intravital multiphoton imaging shows that the regenerating bone in the lesion, with its growing and enclosed vasculature, is closely aligned with the adjacent calvarial bone of the former wound edge (Fig. 2a, Supplementary Movie 1). However, analysis of sagittal sections shows that the vasculature in the lesion and vessels in the adjacent uninjured bone and marrow do not have direct vascular connections, possibly due to a physical barrier created by the separating bone (Fig. 2b, c). Instead, there are many vascular connections between the lesion and the outer periosteal and inner meningeal vasculature (Fig. 2e, see below, Supplementary Fig. 1c-f). Unexpectedly, the newly formed bone attaches and connects only irregularly to the adjacent injured calvarial bone, often leaving a visible gap for several weeks (Fig. 2d). Bundles of collagen fibers cut by the drilling process often remain blunt-ended (Fig. 2b, d). While collagen fibers are preferentially located in densely packed bundles parallel to the surface of the uninjured calvarial bone (Fig. 2b, c), fibers in the newly formed bone are substantially less organized and arranged in an irregular crisscross pattern (Fig. 2b, Supplementary Fig. 2d, Supplementary Movie 2).
To understand how blood flow is established in the expanding vascular network during calvarial bone healing, we performed direct in vivo measurements of red blood cell (RBC) movement using real-time movies and centerline scans to determine RBC velocities at the level of individual vessel segments41. Intravenous injection of fluorescently labeled dextran visualizes lumen-containing vascular sprouts at PLD7 that emerge from the early vascular plexus and extend outwards towards the periosteal vasculature (Fig. 3a). Filopodia decorate the tip of these vascular sprouts, while trailing stalk cells enclose an early vascular lumen connecting to previously established parts of the vessel network (Fig. 3a). Growing sprouts are often filled with stacks of RCBs trapped in blind-ending luminal spaces that are largely stationary and move only passively due to blood circulation in neighboring vessel segments, as visualized by real-time imaging (Supplementary Movie 3, 4). Repetitive centerline scans along individual vessel segments allowed the assembly of a flow map showing the range of RBC velocities as well as perfused and non-perfused luminal spaces (Fig. 3b). In the early expanding vascular network at PLD7, RBC flow velocities are highly variable among individual vessels independent of their diameter, which is likely to reflect dynamic changes in vascular connectivity within the remodeling network (Fig. 3b, c).
In previous work, we had characterized hemodynamic parameters and vessel dimensions in different bone marrow microvessels41. In the current study, we measured blood flow velocities and vessel diameters at PLD9 and PLD21 and used the previously described flow parameters to categorize the expanding and remodeling vascular network as arterial vessels (>1.4 mm/sec), post-arterial capillaries (1.4-.0-8 mm/sec), intermediate vessels (0.8-0.5 mm/sec) and sinusoidal capillaries (< 0.5 mm/sec). At PLD9, the majority of vessels in the early vascular network shows a luminal diameter of 8.2 ± 2.2 µm irrespective of the measured heterogenous flow velocities (Fig. 3d). In the more mature vascular network at PLD21, RBC flow velocities decrease significantly with increasing luminal diameter and differentiation into early arterial and post-arterial vessels of 10.8 ± 2.4 µm and 10.6 ± 2.5 µm, intermediate capillaries of 15.0 ± 5.9 µm and sinusoidal capillaries of 20.8 ± 8.7 µm (Fig. 3e). Microvessels in close proximity to growing bone are strategically located to allow gas exchange and transport nutrients and minerals to bone-forming osteoblasts lining the bone13. To characterize blood flow in these microvessels, we measured RBC velocities at PLD21 in selected vessels close to the edge of growing bone and at locations where vessels are partially enclosed by expanding bone (Fig. 3f, g). Surprisingly, RBC flow velocities are low (0.50 ± 0.16 mm/sec) in these microvessels with small luminal diameter (11.8 ± 16 µm).
This part of the work illustrates how growth and remodeling of the microvasculature lead to dynamic flow changes at the lesion site.
Osteoprogenitors emerge from the periosteum to enter calvarial bone lesion
To gain insight into the early events after calvarial bone injury and the source of osteoprogenitors, identified by expressing the transcription factor Osterix (Osx, encoded by the gene Sp7), drill hole lesions in whole mount calvarial bones of Flk1-GFP and Sp7-mCherry double transgenic mice were analyzed at PLD4 and 6 (Fig. 4a). At this early stage, Osx+ osteoprogenitor cells with high mCherry expression are abundant in the periphery of the lesion area (Supplementary Fig. 3a–d). Sp7-mCherry+ cells originate from the inner periosteal layer adjacent to the meningeal vasculature, which is consistent with previous reports33 (Fig. 4a–d). Sp7-mCherry+ cells increase in the periosteal layer and collectively migrate towards the lesion site (Fig. 4f, Supplementary Fig. 3f, g). The majority of periosteal Sp7-mCherry+ cells infiltrate the lesion as a multicellular layer and align closely to the edge of the calvarial bone injury, a region that also contains microvessels emerging from the meningeal vasculature (Fig. 4a–f). A minor subset of Sp7-mCherry+ cells with spindle-shape morphology appears to migrate as individual cells into the injury site, often in proximity to early microvessels (Fig. 4f, g). However, many of the microvessels in the lesion at a greater distance from the injured bone edge are not associated with Sp7-mCherry+ osteoprogenitors (Fig. 4c–f, h).
Runx2 and Osx are transcription factors promoting different steps in osteogenesis45,46,47. While Runx2 is required at an early stage for the conversion of primitive mesenchymal cells into preosteoblasts, Osx drives the differentiation of these cells into mature osteoblasts18,48. Osx+ osteoprogenitors gradually differentiate into SHG+ bone-matrix secreting Osx+ osteoblasts (Fig. 4j). Immunostaining of Flk1-GFP, Sp7-mCherry calvarial bones shows that Runx2+ osteoprogenitors are abundant at PLD6 in the expanded periosteal layer adjacent to the lesion but also inside the injured area (Supplementary Fig. 3d, e). At this stage, early Sp7-mCherry+ osteoblasts are confined to the periosteum and the surface of the wound edge (Supplementary Fig. 3d, e). While Sp7-mCherry+ osteoblasts at the edge of the lesion are strongly positive for Sp7-mCherry expression, Runx2+ cells with a spindle-shaped morphology and less bright Sp7-mCherry reporter signal are invading the lesion (Supplementary Fig. 3e, f). These cells are likely to represent early Osx+ Runx2+ osteoprogenitors and can be found in proximity of early Flk1-GFP+ endothelial sprouts (Fig. 4h, Supplementary Fig. 3e, f). By contrast, Osx+ Runx2+ double positive cells are absent in regions further away from the lesion area (Supplementary Fig. 3e). PDGFRβ signaling promotes a proliferative, immature and migratory status of skeletal stem and progenitor cells both in development but also fracture repair18,49. PDGFRβ immunostaining is highly abundant inside the lesion, suggesting the presence of immature cells with osteogenic capacity. Many of these PDGFRβ+ cells also express Runx2, but levels of the transcription factor vary considerably in the PDGFRβ+ population, indicating a spectrum of osteogenic differentiation (Supplementary Fig. 3g). Occasionally, in regions with dense fiber deposition, as visualized by SHG imaging, individual PDGFRβ+ Runx2+ cells show an extended, spindle-shaped morphology, suggesting migratory behavior (Supplementary Fig. 3g).
Osteoblasts lining the bone front invade the vascularized calvarial lesion area
To visualize the dynamic behavior of osteoblast lineage cells in relation to ECs during bone healing, calvarial lesions in Flk1-GFP, Sp7-mCherry double reporter mice were repeatedly imaged by intravital multiphoton microscopy (Fig. 5a, Supplementary Fig. 5a). SHG signals indicate that early osteoblastic cells differentiate into bone-forming Sp7-mCherry+ osteoblasts at the edge of growing bone, where they form a dense, multicellular layer lining the surface (Fig. 5a–c). Sp7-mCherry+ osteoblastic cells are first visualized in the injured SHG+ calvarial bone at PLD6. Flk1-GFP+ blood vessels are found close to the bone-lining Sp7-mCherry+ osteoblastic cells and are part of the early vascular network that has penetrated the entire lesion area (Supplementary Fig. 5a). However, the Flk1-GFP+ microvasculature in the uncalcified lesion area is not associated with Sp7-mCherry+ osteoprogenitors (Fig. 5a, d, Supplementary Fig. 5a, b). Bone lining Sp7-mCherry+ osteoblasts form new SHG+ bone matrix on pre-existing bone, as seen at PLD9, and often completely surround themselves with matrix fibers. At the expanding bone front, Sp7-mCherry + osteoblastic cells collectively invade the already vascularized lesion (Supplementary Fig. 5b, c). The leading front of invading Sp7-mCherry+ osteoblastic cells is not surrounded by SHG+ fibers. However, the following Sp7-mCherry+ osteoblasts initiate ossification and form a SHG+ fiber network leaving round and dark spaces containing their cell bodies (Supplementary Fig. 5b). In the following weeks, as seen at PLD14 and PLD21, ossification driven by Sp7-mCherry + osteoblasts progressively replaces the inner uncalcified lesion tissue with newly formed SHG+ bone tissue (Fig. 5a, Supplementary Fig. 5a). As ossification progresses, Flk1-GFP+ microvessels are either gradually displaced or enclosed by the growing bone forming early BM cavities (Fig. 5a–c, Supplementary Fig. 5a, b). Cross sections at PLD14 confirm that a dense layer of Sp7-mCherry + osteoblastic cells lines the entire front of the growing SHG+ calvarial bone. In this region, Sp7-mCherry+ osteoblasts are often completely surrounded by new SHG+ bone matrix. In the adjacent uninjured bone, Sp7-mCherry+ osteocytes are less frequent and show lower levels of Sp7-mCherry expression (Fig. 5d–f).
Taken together, these results show that osteoblastic cells emerge from the peripheral edge of the flat bone injury and collectively migrate into the previously vascularized lesion to initiate ossification and gradually regenerate calvarial bone.
Vascular and bone remodeling in calvarial lesions and femoral fractures
To better understand the role of Osx+ osteoblastic cells and their relationship to microvessels in two different bone types during bone regeneration, we compared calvarial bone lesions with long bone fractures at PLD14 and post-fracture day (PFD) 14, respectively (Fig. 6). The healing process in calvarial bone defects and femoral fractures shows clear differences with respect to the complexity of the regenerating tissue and the involvement of an intermediate avascular callus, which is only present in fractured long bones (Fig. 6a). A common feature of both types of injury is that Osx+ osteoblasts are positioned at the growing bone front, where they form new SHG+ bone matrix, often in proximity of microvessels (Fig. 6c–f). Lesion-associated vessels show high expression of CD31 (CD31high) and Emcn (Emcnhigh) in calvarial and femoral bone (Fig. 6b). To remodel and gradually replace the avascular callus in fractured femurs, growing vessels with a bud-shaped morphology, similar to the previously described CD31high Emcnhigh (type H) vessels at the growth plate, invade the intermediate cartilage at the chondro-osseous junction (Fig. 6a, c, d). Immediately behind this vascular growth front, Osx+ osteoprogenitors and osteoblasts are abundant in the perivascular area and deposit early collagen fibers, as visualized by SHG imaging (Fig. 6c). As endochondral ossification of the callus progresses, the ingrowing bone forms early SHG+ trabecular-like structures through continued fiber and matrix deposition followed by fiber fusion with adjacent collagen bundles to form larger trabecular entities. These early SHG+ collagen bundles are frequently intersected by vascular protrusions with a finger-like appearance (Fig. 6c, d). The healing process in calvarial lesions is clearly different from that of femoral fractures. Osx+ osteoblasts and progenitors in the calvarium line the anterior surface of the growing bone as a multicellular sheet and collectively invade the inner lesion area, which has been fully vascularized earlier (Fig. 6e, f). Bone-forming Osx+ osteoblasts continuously deposit new bone matrix as visualized by the dense SHG+ fiber network, while ossification proceeds inward to closure the lesion site (Fig. 6e, f). During this process, pre-existing Flk1+ blood vessels are either physically displaced and remodeled or enclosed as early bone vessels (Figs. 5d, 6e, f).
Consistent with previous reports50, PDGFRβ+ BM stromal cells in femoral fractures are closely associated with Emcn+ vessels at the osseous-chondral junction and are abundant in the early vascularized and calcified callus at PFD14 (Supplementary Fig. 4a). In calvarial bone lesions, PDGFRβ+ cells are highly abundant not only at PLD6 (Supplementary Fig. 3g), but also in uncalcified regions at PLD14. PDGFRβ+ cells frequently express Runx2, and have elongated nuclei (Supplementary Fig. 4b). Sp7+ osteoblastic cells lining the growing bone front and bone surfaces of small BM-like cavities do not express PDGFRβ. Thus, Sp7+ osteoblastic cells and PDGFRβ+ stromal cells occupy largely complementary regions within calvarial bone lesions (Supplementary Fig. 4c–e).
Osteoclasts remodel regenerating bone in femoral fractures and calvarial bone lesions
Osteoclasts take on important functions in the complex process of bone regeneration after bone injury51,52. Vacuolar ATPases (vATPases), which are critical for extracellular acidification and thereby bone resorption, are a marker of mature osteoclasts. vATPase+ osteoclasts are positioned in fractured femurs at PFD14 in close proximity to bud-shaped vessels, which are invading the intermediate cartilage at the chondro-osseous junction (Fig. 7a). In addition, ATPase+ osteoclasts are abundant in the vicinity of early SHG+ bone matrix deposition and thus the remodeling vasculature of the hard callus (Fig. 7a). To address the role of osteoclasts in calvarial bone regeneration, we analyzed the locations of vATPase+ osteoclasts in calvarial bone lesions relative to Emcn+ microvessels and Sp7+ osteoblastic cells at PLD14 (Fig. 7b). Multinucleated vATPase+ osteoclasts are often found in small cavities of newly formed SHG+ bone containing Emcn+ microvessels, and are frequently located in close proximity to the bone surface. Some vATPase+ osteoclasts are also found in close proximity to Emcn+ microvessels. Notably, the distribution of Sp7+ osteoblast clusters and vATPase+ osteoclasts on the bone surface is mutually exclusive (Fig. 7b, e). MMP9+ staining is abundant in these early bone cavities and is associated with multinucleated cells with osteoclast morphology, suggesting bone resorptive activities (Fig. 7c). Osteoclastic activity extends early BM-like cavities into the adjacent uninjured calvarial bone bridging the gap between ‘old’ and newly formed bone (Fig. 7b). vATPase+ osteoclasts are also found in BM cavities of uninjured bone, where they often occupy opposite surfaces within the BM cavity39, indicating an ongoing remodeling process (Fig. 7d). Our data suggest that osteoclasts remodel early calvarial bone and vascularized cavities in regenerating bone.
Thus, regeneration of calvarial and femoral bone injuries both involves bone-resorbing and remodeling osteoclasts and bone-forming osteoblasts, often in close proximity to microvessels.
Single-cell profiling of bone non-hematopoietic cells after calvarial bone injury
To gain insight into the cellular and molecular changes in non-hematopoietic cells after calvarial bone injury at PLD14, we performed scRNA-seq analysis of lesioned areas and compared the resulting transcriptional profiles with uninjured and age-matched controls (Fig. 8a). Cluster-specific marker genes characterize different cell populations (Fig. 8b–d), including bone mesenchymal stromal cells (BMSCs), osteoblastic cells (OBs), fibroblasts (FBs), smooth muscle cells (SMCs), and endothelial cells (ECs). The number of cells in the BMSC and OB cluster is substantially increased in PLD14 calvarium (Fig. 8e, f), reflecting the ongoing healing process. Transcripts for platelet-derived growth factor receptor β (Pdgfrb), Runt-related transcription factor 2 (Runx2), Osterix (Sp7), and type XXII collagen (Col22a1), which is a recently identified regulator of osteogenesis53 are all upregulated in PLD14 BMSCs and osteoblast lineage cells relative to control (Fig. 8g). Two fibroblast subpopulations can be distinguished (Fig. 8e, f, Supplementary Fig. 6a, b), one of which (FBs-1) remains largely unchanged in number during regeneration and expresses markers of resident fibroblasts (Thy1, Col3a) (Fig. 8g)54. The second fibroblast population (FBs-2) shows expression of insulin-like growth factor-binding protein 6 (Igfbp6), is rare in uninjured samples and profoundly enriched after lesion injury, pointing to a potential role in bone healing and tissue remodeling (Fig. 8e–g). Fibroblasts commonly express high levels of collagens, including collagen I (Col1a1) and collagen III (Col3a1), and show at PLD14 upregulation of collagen VIII (Col8a1), a non-fibrillar lattice-forming collagen that is highly upregulated in vascular injury55. Upregulation is also seen for fibronectin (Fn1), a major fibrillar ECM glycoprotein that binds a variety of growth factors relevant to bone regeneration, including VEGF-A (Vegfa) (Supplementary Fig. 6c)56.
The number of ECs is also higher in PLD14 samples, reflecting increases in multiple EC subclusters relative to control. This includes tip cell ECs (tECs), arterial ECs (aECs), bone marrow (bmECs), skull ECs (skECs, comparable to metaphyseal mpECs in femur50) and osteogenic ECs (osECs) (Supplementary Fig. 7a–d). During calvarial bone repair, osECs show strong expression of genes that support vascular growth and bone regeneration, i.e. Basigin/ EMMPRIN (Bsg), a potent inducer of VEGF signaling57, and osteonectin (spock2), a bone-specific glycoprotein that selectively binds to both hydroxyapatite and collagen with an active role in bone tissue mineralization (Supplementary Fig. 7e)58. A subcluster of arterial-like ECs (alECs-1), a population that has been also observed in long bone50, is largely absent in PLD14 samples (Supplementary Fig. 7a). Pecam1 and Emcn expression are moderately upregulated at PLD14 (Supplementary Fig. 7f). Pecam1 is highly expressed in arterial and arterial-like ECs, whereas Emcn expression is preferentially found in bmECs, skECs and tECs, but not in arterial aECs (Supplementary Fig. 7f), as previously shown31.
To examine how hypoxia and vascularization influence gene expression in healing calvarial bone, we analyzed Hif1a, Vegfa and Angpt2 expression in various cell populations at PLD14. While Hif1a and Angpt2 expression are essentially unchanged, Vegfa expression is slightly increased in MSCs and osteoblasts (OBs) in the injured calvarium compared to controls (Supplementary Fig. 6d, e), reflecting that the lesion is completely vascularized at PLD14. In controls, Vegfa shows a higher expression in bmMSCs compared to other stromal cells suggesting a possible role in vascular remodeling in the uninjured bone. Hif1a expression is generally low in calvarial BMSCs at PLD14 and controls (Supplementary Fig. 6d, e).
Next, we compared Hif1a, Vegfa and Angpt2 expression in different cell populations within calvarial lesions with femoral fractures (Supplementary Fig. 8a–d). The two bone injury models show clear differences in respect to vascularization and Hif1a expression. While Hif1a is not increased in calvarial lesions at PLD14 (Supplementary Figs. 6e, 8e), the transcript is strongly upregulated in BMSC populations from femoral fractures (Supplementary Fig. 8e, f), reflecting the presence of avascular cartilage and ongoing endochondral ossification (Fig. 6a).
Accordingly, Vegfa expression is increased in chondrocytes (Supplementary Fig. 8f), particularly in hypertrophic chondrocytes (Supplementary Fig. 8g, h) that are located in proximity to vascular protrusions at the chondro-osseous junction (Fig. 6a)22.
We provide access to the scRNA-seq data on calvarial lesions through an online cell viewer platform under the following link https://single-cell.mpi-muenster.mpg.de/o/calvarial-lesion-2023. This allows further exploration of the changes in cellular composition and gene expression resulting from the regenerative ossification in calvarial lesions at PLD14.
Notch and Vegfa signaling alter vascular regeneration without affecting calvarial bone healing
Notch signaling is a negative regulator of angiogenic vessel growth in most organs, but in the long bone, the pathway promotes the expansion of CD31high Emcnhigh (type H) capillaries and couples angiogenesis to osteogenesis through the secretion of EC-derived paracrine (angiocrine) factors17,36. To investigate the possible influence of endothelial Notch signaling on angiogenesis and bone healing in the calvarium, we inactivated the gene encoding F-Box and WD Repeat Domain Containing 7 (FBXW7), which mediates the proteasomal degradation of active Notch and thereby limiting its signaling activity59. Adult EC-specific mutants (Fbxw7iΔEC), generated by interbreeding of mice carrying floxed Fbxw7 alleles60 and the Cdh5-CreERT2 transgenic line61, were analyzed in the Flk1-GFP reporter background by longitudinal intravital multiphoton imaging after drill hole injury (Fig. 9a, Supplementary Fig. 9a). Around PLD6, the first Fbxw7iΔEC sprouts appear in the bone lesion and sprouting angiogenesis rapidly expands the vascular network (Fig. 9a–d, Supplementary Fig. 9b). The vascular area of Fbxw7iΔEC mutants is greatly increased compared to controls (Fig. 9c), demonstrating that angiogenesis in flat bone is promoted by endothelial Notch signaling. However, the majority of the newly formed mutant vessels are highly elongated at PLD9, lack a lumen and do not carry blood, whereas microvessels in controls are luminized (Fig. 9a–c, Supplementary Fig. 9c). The Fbxw7iΔEC mutant vasculature inside lesions shows a 2-3-fold increase in vascular sprouts (Fig. 9d). Unlike vascular sprouts in controls, Fbxw7iΔEC tip cells are atypically thickened and extend blebbing protrusions at their surface (Supplementary Fig. 9d). Gradually lumen formation in Fbxw7iΔEC normalizes and hypersprouting decreases, reaching control levels by 4-5 weeks post-lesion (Fig. 9d).
After calvarial bone injury, the onset and progression of ossification in Fbxw7iΔEC mutants is largely comparable to controls with a slight delay at later stages (Fig. 9e, f). In both, mutants and controls, newly formed SHG+ bone matrix forms an interconnected fiber network and surrounds early osteocytes, which are visualized as round and dark speckles in the SHG+ bone matrix (Fig. 9e). As a result of the vascular hypersprouting, numerous Fbxw7iΔEC microvessels are observed in close proximity to the growing bone, but the majority is not perfused (Fig. 9e).
We performed scRNA-seq analysis to investigate whether hypersprouting in Fbxw7iΔEC mutants affects gene transcripts related to hypoxia and ECM formation. Both, Hif1a and Vegfa expression in Fbxw7iΔEC mutants are comparable to controls at PLD14 (Supplementary Fig. 10a, b). The expression of collagens, including the major fibrillary collagens Col1a1 and Col3a1 and the vascular injury related collagen Col8a1, is basically unchanged. Furthermore, ECM components involved in bone regeneration, i.e. Col11a1, Fn1 and Bsg are either unchanged or slightly increased in Fbxw7iΔEC mutants compared to controls (Supplementary Fig. 10c). Similarly, transcripts of MSC and OB differentiation markers are comparable between Fbxw7iΔEC mutants and controls (Supplementary Fig. 10d), suggesting that MSC differentiation into osteoblasts is not affected. Thus, EC-specific Notch activation results in vascular hypersprouting and delayed lumen formation, but has no beneficial effect on ossification in calvarial lesions.
To further investigate the relationship between angiogenesis and osteogenesis during calvarial bone healing, we inactivated the expression of the Notch ligand Delta-like 4 (Dll4) in endothelial cells to inhibit Dll4-Notch interactions62. Adult EC-specific mutants (Dll4iΔEC), generated by interbreeding of mice carrying floxed Dll4 alleles and Cdh5-CreERT2 transgenic mice, were analyzed after drill hole injury at PLD14. Inhibition of endothelial Notch signaling resulted in an increase in vascular density by 1.9-fold, while the progression of bone healing was unaffected (Fig. 10a, b). The regenerating Dll4iΔEC vasculature at PLD14 shows hyperbranching and vessel maturation defects as previously reported for other vascular beds63.
In addition, we overexpressed VEGF-A, a key vascular growth factor, during lesion experiments to promote vascular growth and investigate its effect on calvarial bone healing. To this end, a cDNA encoding a bone-homing version of Vegfa was cloned into the pLIVE vector to allow constitutive protein expression in the liver after hydrodynamic tail vein injection64. Vegfa overexpression results in a 1.6-fold increase in vascular area at PLD14, with some microvessels showing a partially compromised lumen (Fig. 10c, d). Similar to the findings in Notch pathway mutants, the progression of bone healing was not affected by systemic overexpression of VEGF-A (Fig. 10d). In conclusion, endothelial Notch and Vegfa signaling during calvarial bone healing affects vascular sprouting and remodeling without affecting the ossification process.
Discussion
To visualize complex biological events and directly observe cellular dynamics in the bone and BM environment in living mice, various intravital imaging approaches have been developed over the last decade35,37,41,42. Intravital multiphoton imaging of bone regeneration is highly challenging due to the optically dense bone tissue and the slow time course of bone regenerative processes. To date, longitudinal intravital imaging using high-resolution multiphoton microcopy of calvarial bone repair has not been reported at a multiscale level in the same animal until bone healing is complete. Our advanced imaging approach captures the early and highly dynamic sprouting events related to regenerative ossification in calvarial bone lesions. Critical to this approach is the minimal invasiveness of the optical window combined with the high spatial resolution of deep tissue multiphoton microscopy and the repetitive imaging over a prolonged period of time. Alternative methods using skin flaps induce significant inflammatory responses and disrupt the tissue microarchitecture of the regenerating bone due to repetitive surgical procedures prior to each imaging session65. Previous work has shown that the entry of osteoblast precursors in developing and regenerative osteogenesis in long bone is associated with the invasion of growing microvessels49. Subsequent work has highlighted vascular heterogeneity in long bone by showing that specialized CD31hi Emcnhi capillaries promote osteogenesis through interactions with perivascular osteoprogenitor cells14. A similar link between angiogenesis and osteogenesis can be observed in fractured bone where osteoblast precursors are located in close proximity to newly formed blood vessels13,14. VEGF is required for blood vessel invasion into the hypertrophic cartilage of the fracture callus and promotes the replacement of cartilaginous structures by a bony callus16,66,67. In calvarial lesions, a recent report showed that regeneration involves rapid expansion of CD31+ Emcn+ microvessels, which is followed by their maturation into BM vessels31. The same study also proposed that EC coupled to osteoblasts prefer glycolysis, whereas osteoblasts rely more on oxidative phosphorylation and potentially consume more oxygen31. Our own data confirm that early vascular sprouting coincides with osteoprogenitor expansion, but we show that the collective invasion of osteoprogenitors and osteogenesis are not directly coupled to endothelial sprouting and occur at different time points during calvarial bone healing. Thus, the regenerative processes and the role of angiogenic vessel growth are substantially different in flat bone and long bone or during intramembraneous and endochondral ossification, respectively.
Early vascularization of the calvarial bone lesion strongly influences the gene expression profile of oxygen-related genes in bone stromal cells during the healing process. Our scRNA-seq data show that hypoxia-related genes, i.e. Hif1a, Vegfa and Angpt2 are basically unchanged or slightly upregulated at PLD14, reflecting that calvarial ossification and tissue remodeling proceeds into a fully vascularized and perfused lesion, which is very different from femoral fractures. During endochondral ossification, recruitment of mesenchymal progenitor cells that differentiate into chondroblasts contributes to avascular callus formation22. Hypertrophic and hypoxic chondrocytes induce Vegfa-dependent blood vessel invasion into avascular cartilage to allow callus remodeling into early bone tissue66,68. Accordingly, our scRNA-seq data confirm that Hif1a is substantially upregulated in bone stromal cells and Vegfa is increased in CHOs, particularly in hypertrophic CHOs at PFD14.
The structure of the extracellular matrix (ECM) plays an important role in tissue regeneration, including bone healing after injury, and there is clear evidence that extracellular structures are coupled to cell migration and differentiation69,70. A recent report suggests that collagen fiber orientation has a pre-patterning function, guiding tissue mineralization after osteotomy during regeneration of large bone defects44. The authors describe early patterns of collagen fibrils in periosteal and endosteal regions that tend to cross the marrow space. Similarly, we observe the early appearance of a thin collagen network that penetrates the entire lesion prior to calvarial bone ossification, possibly formed by early fibroblasts based on their gene expression of collagens (Col1a1, Col3a1, Col8a1) and fibronectin (Fn1). During tissue mineralization and new bone matrix formation, these thin and parallel collagen fibers are replaced by a differently organized collagen network formed by bone-forming osteoblasts, consisting mainly of collagen type I (Col1a1). Collagen type III (Col3) has been proposed to play a key role in tissue repair based on its expression pattern during healing processes, including bone regeneration71. Mice with reduced Col3 expression show an increased callus volume after long bone fracture, but with less bone, suggesting a role for Col3 in osteogenesis72. In calvarial lesions, Col3a1 gene expression is increased in the FB-2 and MCS populations, but it remains to be shown whether Col3 has a functional role in calvarial bone healing. Osteoclasts are critical for the resorption of calcified bone and play a significant role in bone remodeling during fracture healing51,52. Consistent with previous reports73, we confirm the abundant appearance of osteoclasts in the periosteal callus of fractured femurs suggesting their active participation in the healing process. In calvarial bone repair, the contribution of osteoclasts after bone injury is less well understood. Our data show that osteoclasts play an active role in the early phase of calvarial bone healing when growing bone surrounds remodeling microvessels in the lesion and forms early BM-like cavities. Osteolytic activity by osteoclasts may provide a mechanism by which the gap between ‘old’ and new bone could heal by forming new cavities that bridge both sides, thereby creating space for osteoblastic activity and new bone formation.
Mechanobiological regulation in ECs has been extensively studied, demonstrating that blood flow provides mechanical cues that drive vascular remodeling74 and vessel regression75. After the calvarial bone injury, we observe robust revascularization and restoration of blood flow in the expanding vascular network. The highly variable blood flow dynamics observed in the early vasculature likely contributes to vascular remodeling and gradual functional differentiation of BM microvessels. In addition, the growing bone physically displaces and thereby remodels microvessels in the immediate vicinity, or alternatively surrounds them with bone matrix. A recent study attempted to correlate local oxygen tension in regenerating calvarial bone lesions with the caliber of nearby microvessels and found that vessel size and microvascular density are poor indicators of local oxygen tension31. Our own data show that RCB perfusion varies considerably between individual microvessels, contributing to highly variable blood flow dynamics in the regenerating BM compartment.
Endothelial Notch activity is critical for promoting angiogenesis and osteogenesis in developing bone17. Additionally, VEGF and hypoxia signaling components have been described as important players in angiogenic-osteogenic coupling13,16. However, at the molecular level, the precise mechanism of angiogenesis and its coupling with osteogenesis during fracture repair is not completely understood15. In contrast to fractured femurs, we observe in three different models during calvarial bone repair, i.e. Notch activation and inactivation, and Vegfa overexpression, that profound vascular changes have little effect on bone regeneration, possibly due to uncoupling of endothelial sprouting from collective invasion of osteoprogenitors. A more detailed analysis of this striking difference between calvarial and femoral bone healing is required to understand the molecular mechanism behind the uncoupling of vascular sprouting from co-migrating osteoprogenitors. A deeper understanding of the highly complex regenerative processes after bone injury is critical for the long-term success of strategies to improve bone regeneration and overcome major challenges in orthopedic surgery. Here, we establish a unique longitudinal intravital multiphoton imaging approach to visualize calvarial bone regeneration in living mice, including dynamic sprouting, remodeling and maturation of the calvarial bone vasculature and gradual new bone formation through the collective activity of osteoblastic cells. We show that sprouting blood vessels form a vascular network in the lesion before the entry of osteoprogenitors, implying that angiogenesis and osteogenesis occur at different stages of the repair process. Sprouting vessels originating from the meningeal layer vascularize the entire lesion, while osteoprogenitors gradually mediate ossification from the edge of the injured bone. Thus, the process of calvarial bone regeneration clearly differs from long bone fracture healing with respect to the functional role of angiogenic vessels, the co-invasion of vessels and osteoprogenitors, and the expression of oxygen-related genes. Our comprehensive study of vascular regeneration during calvarial bone healing provides fundamental insight into the regeneration of flat bone, which has important implications for bioengineering but also for the development of future therapeutic strategies to improve bone regeneration.
Methods
All animal experiments were performed according to the institutional guidelines and laws, approved by local animal ethical committee and were conducted at the University of Münster and the Max Planck Institute for Molecular Biomedicine with necessary permissions (84-02.04.2018.A171, 81-02.04.2019.A164) granted by the Landesamt für Natur, Umwelt und Verbraucherschutz (LANUV) of North Rhine-Westphalia, Germany.
Multiphoton imaging setup
We used a TriM Scope II multi photon system from LaVision BioTec (Bielefeld, Germany) to visualize immune labeling and SHG generated by collagen in the bone41. The setup is a single-beam instrument with an upright Olympus BX51 WI microscope stand that is equipped with highly sensitive NDD detectors close to the objective lens. The TriM Scope II is fitted with a Coherent Scientific Chameleon Ultra II Ti:Sapphire laser and a Coherent Chameleon Compact OPO. A 20x IR objective lens (Olympus XLUMPlanFL; NA 1.0) with a working distance of 2.0 mm was used. The microscope is equipped with a pair of x-y galvanometric mirrors used to scan at a scanning speed of up to 1200 lines/s. The maximal laser power (850 nm) on the object was 10–20 mW at superficial areas and 80–100 mW when imaging at large depths. Dichromatic mirrors and band pass filters spectrally separate the emitted light before the signal is detected using attached photomultiplier tubes (PMT; Hamamatsu H67080-01 (blue channel), H67080-20 (green and red channels). The following detection channels were used: red (560–680 nm), green (475–575 nm) and blue (370–470 nm). 3D-images were acquired and processed with LaVision BioTec ImSpector Pro.
Fluorescence microscopy
Bone immunostaining performed as described previously76, bone sections were washed in ice-cold PBS and permeabilized with ice-cold 0.3% Triton-X-100 in PBS for 10 mins at room temperature (RT). Samples were incubated in blocking solution (5% heat-inactivated donkey serum in 0.3% Triton-X-100) for 1 h at RT. Primary antibodies: rat monoclonal anti-Endomucin (1:200, Santa Cruz, Cat# sc-65495, clone V.7C7), goat polyclonal anti-CD31 (1:200, R&D, Cat# AF3628), goat polyclonal anti-Pdgfrb (1:200, R&D, Cat# AF1042), rabbit polyclonal anti-Osterix (1:200, Abcam, Cat# ab22552), rabbit polyclonal anti-Acan (1:200, Millipore, Cat#AB1031), rabbit polyclonal anti-vATPaseB1/B2 (1:200, Abcam, Cat# 200839), rabbit polyclonal anti-Runx2 (1:200, Abcam, Cat# 192256) were diluted in 5% donkey serum mixed PBS and incubated overnight at 4 °C. Next, slides were washed 3 to 5 times in PBS in 5-10 min intervals. Wholemount calvarial bones with drill hole lesions were fixed with PFA (2%) overnight at 4 °C and stained using primary antibody rabbit polyclonal anti-Osterix (1:200, Abcam, Cat# ab22552) for 3 days at 4 °C to allow for sufficient tissue penetration of the antibodies. Species-specific Alexa Fluor secondary antibodies (goat anti-rat IgG Alexa Fluor 594 (1:200, Thermo Fischer Scientific, Cat# A21209), donkey anti-rabbit IgG Alexa Fluor 647 (1:200, Thermo Fischer Scientific, Cat# A31573), donkey anti-goat IgG Alexa Fluor 647 (1:200, Thermo Fischer Scientific, Cat# A21447), donkey anti-rat IgG Alexa Fluor 488 (1:200, Thermo Fischer Scientific, Cat# A21208) were diluted in PBS were added and incubated for 3 h at RT or overnight at 4 °C.
Construction of fluorescent composite and tile scan images
Multiphoton images obtained with the microscope ImspectorPro acquisition software were analyzed, processed and assembled using ImageJ (open source NIH software, http://imagej.nih.gov/ij). For tile scans images a 20% overlap were recorded and stitched using the stitching plugin from ImageJ.
Animal models
All mice used were on a C57/Bl6J background. Female mice were used between 8–12 weeks old unless stated otherwise. Flk1-GFP + transgenic mice (STOCK Kdrtm2.1Jrt/J, RRID:IMSR_JAX:017006)77 were used to label the bone vasculature. Sp7-mCherry+ transgenic mice (STOCK Tg(Sp7/mCherry)2Pmay/J, RRID:IMSR_JAX:024850)78 were used to visualize osteoprogenitor and osteoblasts. Vascular reporter Flk1-GFP mice were crossed to Fbxw7 lox/lox:Cdh5Cre-ERT2 (Fbxw7iΔEC) (B6;129-Fbxw7tm1Iaai/J, RRID:IMSR_JAX:017563: Tg(Cdh5-cre/ERT2)1Rha, MGI:3848982)79,80 to study Notch GOF in endothelial cells. Notch LOF in endothelial cells was studied in Dll4 lox/lox:Cdh5Cre-ERT2 mice (Dll4iΔEC) (Dll4tm1Frad, MGI:3828266: Tg(Cdh5-cre/ERT2)1Rha, MGI:3848982)62. For inducible Cre-mediated recombination, mice received daily intraperitoneal (i.p.) injections of tamoxifen (4 mg/kg body weight) from day1 to day 5 (d1-d5) one week before the cranial window and calvarial drill hole lesion surgery.
For fracture healing model, we used 10-week-old female mice for the fracture experiments. Mice were anesthetized by using a ketamine hydrochloride/xylazine mixture (80 /12 mg/kg body weight, i.p.) the left leg was fractured with three-point bending. It was stabilized with an intramedullary nail (hollow needle 23 G) as described previously81. Carprofen (4 mg/kg intra muscular) was given as an analgesic and further on at 24-hour intervals when required. Mice were sacrificed by cervical dislocation after post-fracture surgery day at 14 and 12 weeks wild-type female were used as control.
Bone sample preparation
Mice were sacrificed and femurs were harvested and fixed immediately in ice-cold 2% paraformaldehyde (PFA) for 6 to 8 h under gentle agitation. Bones were decalcified in 0.5 M EDTA for 16 to 24 h at 4 °C under gentle shaking agitation, which was followed by overnight incubation in cryopreservation solution (20% sucrose, 2% PVP) and embedded in in bone embedding medium (8% gelatine, 20% sucrose, 2% PVP). Samples were stored at −80 °C. For immunofluorescence staining 90 to 100 μm-thick cryosections were prepared.
Surgical preparation for longitudinal intravital imaging
We used a chronic cranial window to provide clear optical access to the calvarial bone and bone microvessels41,82,83,84. A schematic of the cranial window construction and fixation of the mouse using the head immobilization device is shown in Fig. 1a. Mice were anesthetized with a combination of ketamine/xylazine. A circular incision was made in the scalp to expose the underlying dorsal skull surface. A dental drill (diameter: 500 µm) was used to insert a drill hole lesion into the parietal bone (Fig. 1b). A round glass cover slip with a hanging drop of sterile PBS was placed over the bone lesion and fixed with dental acrylic. A custom-designed titanium ring was glued on top to allow head immobilization and the elimination of motion artifacts. Dexamethason was used to prevent inflammatory responses. Ketamine/xylazine anesthesia was used for intravital imaging and mice were kept on a 37 °C heat pad to keep the body temperature constant41,82. The physical condition of the mice was frequently controlled by observing their breathing frequency and their overall condition.
Bone stromal cell preparation for single cell RNA sequencing (scRNA-seq)
Skulls with calvarial lesions (diameter: 1 mm) at PLD14 with their corresponding age-matched controls were harvested, cleaned from attached surrounding tissue and collected in digestion enzyme solution (Collagenase type I and IV, 2 mg/ml). Next, bones were cut into small pieces. Samples were digested for 30 min at 37 °C under gentle agitation. Digested samples were transferred to 70 µm strainers in 50 ml tubes to obtain a single–cell suspension, which was resuspended in blocking solution (1% BSA, 1 mM EDTA in PBS without Ca2+/Mg2+), centrifuged at 300 × g for 5 mins, washed 2–3 times with ice-cold blocking solution, and filtered through 50 µm strainers. Pellets were resuspended in respective volume of blocking solution. Single cell suspensions were subjected to lineage depletion using lineage cell depletion kit (MACS, cat#130-090-858) following the manufacturer’s instructions. Next, lineage negative cells were depleted by CD45 and CD117 using microbeads (MACS, cat#130-052-301 and cat#130-091-224) from lineage negative (Lin-) bone cells to enrich bone stromal cells. Single cell suspensions were processed with BD Rhapsody and scRNA-seq libraries were evaluated and quantified by Agilent Bioanalyzer using High sensitivity DNA kit (cat#5067-4626) and Qubit (ThermoFisher Scientific, Cat# Q32851). Individual libraries were diluted to 4 nM and pooled for sequencing. Pooled libraries were sequenced by using High Output kit (150 cycle) (Illumina cat#TG-160-2002) with a NextSeq500 sequencer (Illumina).
Single cell RNA-seq data analysis
Sequencing data of FASTQ format were processed with BD Rhapsody WTA Analysis pipeline (version 1.0) on SevenBridges Genomics online platform (SevenBridges) and expression matrix were used for further data analysis. Data normalization, dimensionality reduction and visualization were performed using Seurat (version 4.3.0) if not specified otherwise.
For initial quality control of the extracted gene-cell matrices, we filtered cells with parameters nFeature_RNA > 500 & nFeature_RNA < 6000 for number of genes per cell and percent.mito <25 for percentage of mitochondrial genes and genes with parameter min.cells = 3. Filtered matrices were normalized by LogNormalize method with scale factor=10,000. Variable genes were found using FindVariableFeatures function with parameters of selection.method = “vst”, nfeatures = 2000, trimmed for the genes related to cell cycle (GO:0007049) and then used. FindIntegrationAnchors and IntegrateData with default options were used for the data integration. Statistically significant principal components were determined by JackStraw method and the first 7 principal components were used for UMAP non-linear dimensional reduction.
Unsupervised hierarchical clustering analysis was performed using FindClusters function in Seurat package. We tested different resolutions between 0.1 ~ 0.9 and selected the final resolution using clustree R package to decide the most stable as well as the most relevant for our previous knowledges. Cellular identity of each cluster was determined by finding cluster-specific marker genes using FindAllMarkers function with minimum fraction of cells expressing the gene over 25% (min.pct=0.25), comparing those markers to known cell type-specific genes from previous studies and further confirmed using the R package SingleR, which compares the transcriptome of each single cell to reference datasets to determine cellular identity.
For subclustering analysis, we isolated specific cluster(s) using subset function, extracted data matrix from the Seurat object using GetAssayData function and repeated the whole analysis pipeline from data normalization. FeaturePlot, VlnPlot and DoHeatmap functions of Seurat package were used for visualization of selected genes.
Blood flow measurements
For in vivo imaging of blood flow dynamics at cellular resolution in microvessels TexasRed-dextran (70.000 MW, Molecular Probes) was injected into mice through the tail. The dextran dye labels the blood plasma, but is excluded from RBCs which appear as dark objects moving against a bright fluorescent background allowing to visualize the dynamic movements of RBCs in microvessels. Real-time movies were recorded to animate the blood flow dynamics in the calvarial lesion area, and blood flow velocities in microvessels were measured using center line scans as described previously41,83. Up to 25 individual vessel segments were measured in random order. To ensure flow velocities remained constant, we measured selected vessels twice at different time points, i.e. at the beginning and end of an experiment. We used a python script implemented in the acquisition software to export velocity data of single RBC streaks.
VEGF-A plasmid construction and overexpression
To generate the pLIVE-VEGFA165-HA-MP-Asp8x bone-homing protein containing VEGF165 fused to HA-tag, metalloprotease and 8x Asp peptide sequences, a cDNA fragment encoding amino acids 1-191 of human VEGFA was amplified via PCR using the following oligonucleotide primers: VEGFA-AscI-Fwd: 5’- ATGAACTTTCTGCTGTCT-3’ and VEGFA-XhoI-Rev: 5’-CCGCCTCGGCTTGTCACATCTGCA-3’ and annealed with the NEBuilder Assembly Cloning Kit. 8-10-week-old Flk1-GFP mice were used for hydrodynamic tail vein injection. Animals were injected with 0.5 μg g−1 (plasmid/body weight) pLIVE-Vegfa plasmid suspended in TransIT606 hydrodynamic delivery solution (Mirus, Cat# MIR5340). The appropriate amount of plasmid was suspended in an injection volume of 10% of the body weight and injected via the tail vein in 5-7 s as previously reported. Mice were used after 3 days for drill hole lesion injury.
Image analysis
The ImageJ was used to analyze and quantify the newly formed bone area in the calvarial drill hole lesion. Three imaging planes at different depths (typically 50 µm, 150 µm, 250 µm) were used to calculate the newly formed bone area in the drill hole lesion. To determine the vascular area in the calvarial lesion, the maximal projection image was transformed into a binary image and the vessel area in the circular lesion area was measured. Number of vascular sprouts and branch points were analyzed by selecting three representative ROIs (280µm x 280µm) from maximum projection images (z = 20 µm), that were transformed into binary images with ImageJ to further analyze sprout numbers using AngioTool85. To calculate perfused vessel area, the complete vascular area of the binary images was measured and perfused vessel area was analyzed manually based on visual inspection.
Statistics and reproducibility
Statistical analysis and design of micrographs and plots was performed with GraphPad Prism 10 Software. An unpaired two-tailed Student’s t test was used for comparison between two groups. For comparison between two groups and multiple time points, two-way ANOVA with multiple comparisons was used. Data is presented as mean +/- SD. Differences were considered statistically significant at p < 0.05. Reproducibility was ensured by three or more biologically independent experiments. Source data are provided as a Source Data file.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
The single-cell RNA-seq data generated in this study have been deposited in the Gene Expression Omnibus (GEO) under accession numbers GSE154247 and GSE262350. All other data supporting the findings of this study are available from the corresponding authors on reasonable request. Source data are provided with this paper.
References
Fayaz, H. C. et al. The role of stem cells in fracture healing and nonunion. Int Orthop. 35, 1587–1597 (2011).
Andrzejowski, P. & Giannoudis, P. V. The ‘diamond concept’ for long bone non-union management. J. Orthop. Traumatol. 20, 21 (2019).
Gustilo, R. B., Gruninger, R. P. & Davis, T. Classification of type III (severe) open fractures relative to treatment and results. Orthopedics 10, 1781–1788 (1987).
Schmidmaier, G. et al. Bone morphogenetic proteins in critical-size bone defects: what are the options? Injury 40, S39–S43 (2009).
Ehnert, S. et al. Use of in vitro bone models to screen for altered bone metabolism, osteopathies, and fracture healing: challenges of complex models. Arch. Toxicol. 94, 3937–3958 (2020).
Victoria, G. et al. Bone stimulation for fracture healing: What’s all the fuss? Indian J. Orthop. 43, 117–120 (2009).
Schlundt, C. et al. Clinical and research approaches to treat non-union fracture. Curr. Osteoporos. Rep. 16, 155–168 (2018).
Menger, M. M., et al., The vascularization paradox of non-union formation. Angiogenesis 25, 279–290 (2022).
Saran, U., Gemini Piperni, S. & Chatterjee, S. Role of angiogenesis in bone repair. Arch. Biochem Biophys. 561, 109–117 (2014).
Baker, C. E. et al. Bone Fracture Acute Phase Response-A Unifying Theory of Fracture Repair: Clinical and Scientific Implications. Clin. Rev. Bone Min. Metab. 16, 142–158 (2018).
Menger, M. M. et al. Vascularization Strategies in the Prevention of Nonunion Formation. Tissue Eng. Part B Rev. 27, 107–132 (2021).
Stegen, S., van Gastel, N. & Carmeliet, G. Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone 70, 19–27 (2015).
Grosso, A. et al. It takes two to tango: coupling of angiogenesis and osteogenesis for bone regeneration. Front Bioeng. Biotechnol. 5, 68 (2017).
Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323–328 (2014).
Dirckx, N., Van Hul, M. & Maes, C. Osteoblast recruitment to sites of bone formation in skeletal development, homeostasis, and regeneration. Birth Defects Res. C. Embryo Today 99, 170–191 (2013).
Schipani, E. et al. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J. Bone Min. Res. 24, 1347–1353 (2009).
Ramasamy, S. K. et al. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376–380 (2014).
Bohm, A. M. et al. Activation of Skeletal Stem and Progenitor Cells for Bone Regeneration Is Driven by PDGFRbeta Signaling. Dev. Cell 51, 236–254 e12 (2019).
Loi, F. et al. Inflammation, fracture and bone repair. Bone 86, 119–130 (2016).
Hurst, S. M. et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705–714 (2001).
Geris, L. et al. Angiogenesis in bone fracture healing: a bioregulatory model. J. Theor. Biol. 251, 137–158 (2008).
Bahney, C. S. et al. Cellular biology of fracture healing. J. Orthop. Res. 37, 35–50 (2019).
Wei, J. et al. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell 161, 1576–1591 (2015).
Ono, N. & Kronenberg, H. M. Bone repair and stem cells. Curr. Opin. Genet Dev. 40, 103–107 (2016).
Rhinelander, F. W. The normal microcirculation of diaphyseal cortex and its response to fracture. J. Bone Jt. Surg. Am. 50, 784–800 (1968).
Hirao, M. et al. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J. Biol. Chem. 281, 31079–31092 (2006).
Dy, P. et al. Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev. Cell 22, 597–609 (2012).
Jeffery, E. C. et al. Bone marrow and periosteal skeletal stem/progenitor cells make distinct contributions to bone maintenance and repair. Cell Stem Cell 29, 1547–1561.e6 (2022).
McGee-Lawrence, M. E. & Razidlo, D. F. Induction of fully stabilized cortical bone defects to study intramembranous bone regeneration. Methods Mol. Biol. 1226, 183–192 (2015).
Samsonraj, R. M. et al. A versatile protocol for studying calvarial bone defect healing in a mouse model. Tissue Eng. Part C. Methods 23, 686–693 (2017).
Schilling, K. et al. High-resolution imaging of the osteogenic and angiogenic interface at the site of murine cranial bone defect repair via multiphoton microscopy. Elife 11, e83146 (2022)
Rindone, A. N. et al. Quantitative 3D imaging of the cranial microvascular environment at single-cell resolution. Nat. Commun. 12, 6219 (2021).
Zhang, X. et al. Msx1(+) stem cells recruited by bioactive tissue engineering graft for bone regeneration. Nat. Commun. 13, 5211 (2022).
Dumanian, Z. P. et al. Repair of critical sized cranial defects with BMP9-transduced calvarial cells delivered in a thermoresponsive scaffold. PLoS One 12, e0172327 (2017).
Kim, J. & Bixel, M. G. Intravital multiphoton imaging of the bone and bone marrow environment. Cytometry A 97, 496–503 (2020).
Sivaraj, K. K. & Adams, R. H. Blood vessel formation and function in bone. Development 143, 2706–2715 (2016).
Lo Celso, C. et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457, 92–96 (2009).
Acar, M. et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature 526, 126–130 (2015).
Furuya, M. et al. Direct cell-cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo. Nat. Commun. 9, 300 (2018).
Mazo, I. B. et al. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J. Exp. Med. 188, 465–474 (1998).
Bixel, M. G. et al. Flow Dynamics and HSPC Homing in Bone Marrow Microvessels. Cell Rep. 18, 1804–1816 (2017).
Reismann, D. et al. Longitudinal intravital imaging of the femoral bone marrow reveals plasticity within marrow vasculature. Nat. Commun. 8, 2153 (2017).
Ortinau, L. C. et al. Identification of Functionally Distinct Mx1+alphaSMA+ Periosteal Skeletal Stem Cells. Cell Stem Cell 25, 784–796 e5 (2019).
Petersen, A. et al. A biomaterial with a channel-like pore architecture induces endochondral healing of bone defects. Nat. Commun. 9, 4430 (2018).
Nakashima, K. et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29 (2002).
Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765–771 (1997).
Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755–764 (1997).
Zhou, X. et al. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl Acad. Sci. USA 107, 12919–12924 (2010).
Maes, C. et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 19, 329–344 (2010).
Sivaraj, K. K. et al. Mesenchymal stromal cell-derived septoclasts resorb cartilage during developmental ossification and fracture healing. Nat. Commun. 13, 571 (2022).
Ono, T. & Nakashima, T. Recent advances in osteoclast biology. Histochem Cell Biol. 149, 325–341 (2018).
Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337–342 (2003).
Zhao, W., et al. Decreased Trabecular Bone Mass in Col22a1-Deficient Mice. Cells. 10, 3020 (2021)
Wei, K., H. N. Nguyen, and M. B. Brenner, Fibroblast pathology in inflammatory diseases. J. Clin. Invest. 131, e149538 (2021).
Adiguzel, E. et al. Type VIII collagen signals via beta1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration. Matrix Biol. 32, 332–341 (2013).
Martino, M. M. et al. Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3, 100ra89 (2011).
Bougatef, F. et al. EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. Blood 114, 5547–5556 (2009).
Termine, J. D. et al. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 26, 99–105 (1981).
Kar, R. et al. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Cancer Rep. (Hoboken) 4, e1369 (2021).
Thompson, B. J. et al. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205, 1395–1408 (2008).
Sorensen, I., Adams, R. H. & Gossler, A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113, 5680–5688 (2009).
Suchting, S. et al. The notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl Acad. Sci. USA 104, 3225–3230 (2007).
Pitulescu, M. E. et al. Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. Nat. Cell Biol. 19, 915–927 (2017).
Suda, T. & Liu, D. Hydrodynamic gene delivery: its principles and applications. Mol. Ther. 15, 2063–2069 (2007).
Park, D. et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10, 259–272 (2012).
Gerber, H. P. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623–628 (1999).
Hu, K. & Olsen, B. R. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J. Clin. Invest 126, 509–526 (2016).
Claes, L., Recknagel, S. & Ignatius, A. Fracture healing under healthy and inflammatory conditions. Nat. Rev. Rheumatol. 8, 133–143 (2012).
Schwarz, C. et al. The Interaction of BMP2-Induced Defect Healing in Rat and Fixator Stiffness Modulates Matrix Alignment and Contraction. JBMR 2, 174–186 (2018).
Rozario, T. & DeSimone, D. W. The extracellular matrix in development and morphogenesis: a dynamic view. Dev. Biol. 341, 126–140 (2010).
Merkel, J. R. et al. Type I and type III collagen content of healing wounds in fetal and adult rats. Proc Soc. Exp. Biol. Med. 187, 493–497 (1988).
Miedel, E. L. et al. Type III collagen modulates fracture callus bone formation and early remodeling. J. Orthop. Res. 33, 675–84 (2015).
Schell, H. et al. Osteoclastic activity begins early and increases over the course of bone healing. Bone 38, 547–554 (2006).
Li, Y. S., Haga, J. H. & Chien, S. Molecular basis of the effects of shear stress on vascular endothelial cells. J. Biomech. 38, 1949–1971 (2005).
Zhou, Q. et al. Association between erythrocyte dynamics and vessel remodelling in developmental vascular networks. J. R. Soc. Interface 18, 20210113 (2021).
Sivaraj, K. K., et al. YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells. Elife. 9, e50770 (2020).
Xu, Y. et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188, 115–130 (2010).
Strecker, S. et al. Generation and characterization of Osterix-Cherry reporter mice. Genesis 51, 246–258 (2013).
Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483–486 (2010).
Hoeck, J. D. et al. Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun. Nat. Neurosci. 13, 1365–1372 (2010).
Schmitz, N. et al. A novel MRI compatible mouse fracture model to characterize and monitor bone regeneration and tissue composition. Sci. Rep. 10, 16238 (2020).
Holtmaat, A. et al. Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat. Protoc. 4, 1128–1144 (2009).
Shih, A. Y. et al. Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain. J. Cereb. Blood Flow. Metab. 32, 1277–1309 (2012).
Stewen, J. & Bixel, M. G. Intravital imaging of blood flow and hspc homing in bone marrow microvessels. Methods Mol. Biol. 2017, 109–121 (2019).
Zudaire, E. et al. A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385 (2011).
Acknowledgements
We would like to thank M. Wewer and M. Böttcher from Miltenyi Biotec (formerly LaVision BioTec) for sharing their expertise and technical support on the TriMScope II. Funding was provided by the Max Planck Society, the University of Münster and the European Research Council (AdG 786672 PROVEC). V.M. is part of the Cells in Motion International Max Planck Research School (CiM-IMPRS).
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
M.G.B. and R.H.A. designed experiments and interpreted results. M.G.B. generated and characterized mouse reporter and mutant lines, conducted calvarial drill hole lesion experiments and intravital multiphoton imaging experiments, their analysis and quantification, calvarial bone sectioning and immune staining, R.S., M.T., K.K.S. and M.G.B. performed bone fracture experiments. K.K.S. performed femoral fracture sectioning, immune staining, and all single cell RNA sequencing experiments. V.M. performed calvarial bone sectioning and immune staining, A.A. performed whole-mount calvarial bone staining, S.A. cloned pLIVE plasmids. B.-I.K. performed hydrodynamic injection, M.G.B., H.-W.J. and K.K.S. analyzed the scRNA-sequencing data. K.K. programed and provided the cell viewer platform scRNA-seq analysis, M.G.B. and R.H.A. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Jan Tuckermann and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bixel, M.G., Sivaraj, K.K., Timmen, M. et al. Angiogenesis is uncoupled from osteogenesis during calvarial bone regeneration. Nat Commun 15, 4575 (2024). https://doi.org/10.1038/s41467-024-48579-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-024-48579-5